Regional variations in the transport of interleukin-1α across the blood-brain barrier in ICR and aging SAMP8 mice

NeuroImmunoModulation

Volumn 8, Issue 4, 2000, Pages 165-170

  Moinuddin, Asif ^b   Morley, John E ^b   Banks, William A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Aging; Amyloid protein; Blood brain barrier; Cerebellum; CNS; Cytokines; Influx constants; Interleukin 1; Pons medulla; SAMP8; Transport

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; INTERLEUKIN 1ALPHA; SUCROSE;

AGE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN REGION; CELL MEMBRANE TRANSPORT; GENE OVEREXPRESSION; MEDULLA OBLONGATA; MOUSE; NONHUMAN; PONS; PRIORITY JOURNAL;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; INTERLEUKIN-1; KINETICS; MICE; MICE, INBRED ICR; MICE, MUTANT STRAINS; SERUM ALBUMIN; SUCROSE;

EID: 0034467123     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054814     Document Type: Article

References (39)

1. Banks WA, Kastin AJ, Broadwell RD: Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995;2:241-248.
2. Stitt JT: Passage of immunomodulators across the blood-brain barrier. Yale J Biol Med 1990; 63:121-131.
3. Watkins LR, Maier SF, Goehler LE: Cytokine-to-brain communication: A review & analysis of alternative mechanisms. Life Sci 1995;57: 1011-1026.
4. 2 levels in several brain areas as determined by microdialysis. Am J Physiol 1992;262:E246-E251.
5. Banks WA: Cytokines, CVOs, and the blood-brain barrier; in Ader R, Felten DL, Cohen N (eds): Psychoneuroimmunology. San Diego, Academic Press, in press.
6. Mecocci P, Parnetti L, Reboldi GP, Santucci C, Gaiti A, Ferri C, Gemini I, Romagnoli M, Cadini D, Senin U: Blood-brain-barrier in a geriatric population: Barrier function in degenerative and vascular dementias. Acta Neurol Scand 1991;84:210-213.
7. Rapoport SI: Blood-brain barrier permeability in senescent rats. J Gerontol 1978;34:162-169.
8. Shah GN, Mooradian AD: Age-related changes in the blood-brain barrier. Exp Gerontol 1997; 32:501-519.
9. Stewart PA, Magliocco M, Hayakawa K, Farrell CL, Del Maestro RF, Girvin J, Kauffmann JC, Vinters HV, Gilbert J: A quantitative analysis of blood-brain barrier ultrastructure in the aging human. Microvasc Res 1987;33:270-282.
10. Öztas B, Kaya M, Camurcu S: Age related changes in the effect of electroconvulsive shock on the blood brain barrier permeability in rats. Mech Ageing Dev 1990;51:149-155.
11. Fiala AM, Zhang L, Gan X, Sherry B, Taub D, Graves MC, Hama S, Way D, Weinand M, Witte M, Lorton D, Kuo YM, Roher AE: Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 1998;4:480-489.
12. Kalaria RN: Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann NY Acad Sci 1997; 826:263-271.
13. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP: Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 1997;68: 1870-1881.
14. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102.
15. Flood JF, Morley JE, Roberts E: Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease. Proc Natl Acad Sci USA 1991;88:3363-3366.
16. Matsumura Y, Kitamura E, Miyoshi K, Yamamoto Y, Furuyama J, Sugihara T: Japanese siblings with missense mutation (717Val→Ile) in amyloid precursor protein of early-onset Alzheimer's disease. Neurology 1996;46:1721-1723.
17. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD: Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000;283:1571-1577.
18. Rosenberg RN: The molecular and genetic basis of AD: The end of the beginning. The 2000 Wartenberg lecture. Neurology 2000;54:2045-2054.
19. Flood JF, Morley JE: Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol Aging 1993;14:153-157.
20. Flood JF, Morley JE: Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 1998;22:1-20.
21. Banks WA, Ortiz L, Plotkin SR, Kastin AJ: Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991;259:988-996.
22. Gutierrez EG, Banks WA, Kastin AJ: Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol 1994;55:153-160.
23. Maness LM, Banks WA, Zadina JE, Kastin AJ: Selective transport of blood-borne interleukin-1α into the posterior division of the septum of the mouse brain. Brain Res 1995;700:83-88.
24. Ueno M, Dobrogowska DH, Vorbrodt AW: Immunocytochemical evaluation of the blood-brain barrier to endogenous albumin in the olfactory bulb and pons of senescence-accelerated mice (SAM). Histochem Cell Biol 1996; 105:203-212.
25. Ueno M, Akiguchi I, Hosokawa M, Shinnou M, Sakamoto H, Takemura M, Higuchi K: Age-related changes in the brain transfer of blood-borne horseradish peroxidase in the hippocampus of senescence-accelerated mouse. Acta Neuropathol (Berl) 1997;93:233-240.
26. Vorbrodt AW, Dobrogowska DH, Ueno M, Tarnawski M: A quantitative immunocytochemical study of blood-brain barrier to endogenous albumin in cerebral cortex and hippocampus of senescence-accelerated mice (SAM). Folia Histochem Cytobiol 1995;33:229-237.
27. Blasberg RG, Fenstermacher JD, Patlak CS: Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 1983;3:8-32.
28. Patlak CS, Blasberg RG, Fenstermacher JD: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
29. Banks WA, Kastin AJ, Ehrensing CA: Diurnal uptake of circulating interleukin-1α by brain, spinal cord, testis and muscle. Neuroimmunomodulation 1998;5:36-41.
30. Banks WA, Kastin AJ: Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin. Peptides 1998; 19:883-889.
31. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
32. Banks WA, Clever CM, Farrell CL: Partial saturation and regional variation in the blood to brain transport of leptin in normal weight mice. Am J Physiol 2000;278:E1158-E1165.
33. Banks WA, Kastin AJ, Jaspan JB: Regional variation in transport of pancreatic polypeptide across the blood-brain barrier of mice. Pharmacol Biochem Behav 1995;51:139-147.
34. Banks WA, Kastin AJ, Pan W: Uptake and degradation of blood-borne insulin by the olfactory bulb. Peptides 1999;20:373-378.
35. Banks WA, DiPalma CR, Farrell CL: Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999;20:1341-1345.
36. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI: Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991;325:703-709.
37. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-1561.
38. Banks WA, Farr SA, Morley JE: Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse. J Gerontol A Biol Sci Med Sci, in press.
39. Ziylan YZ, Robinson PJ, Rapoport SI: Blood-brain barrier permeability to sucrose and dextran after osmotic opening. Am J Physiol 1984; 247:R634-R638.